Q2 2018 Holdings
Filed 2018-08-14 | 6 holdings | $65.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Urogen Pharma Ltd.(URGN) | Common Stock | M96088105 | $39.3K | 789,297 | 60.4% |
| Mersana Therapeutics, Inc. | Common Stock | 59045L106 | $17.1K | 955,709 | 26.3% |
| Immune Design Corp. | Common Stock | 45252L103 | $5.6K | 1,236,394 | 8.7% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common Stock | 00847L100 | $2.5K | 5,062,363 | 3.8% |
| Eagle Pharmaceuticals, Inc.(EGRX) | Common Stock | 269796108 | $513 | 6,777 | 0.8% |